Top Markets
Coin of the day
Joyzyme Group Limited Joyzyme Group Limited

Joyzyme Group Limited

8622
Rang in Aktien #32056
Huakang Biomedical Holdings Company Limited operates as an investment holding... Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
Aktienkurs
$0.02187539
Marktkapitalisierung
$11.28M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-54.99%
Land
HK
Handel Joyzyme Group Limited (8622)

Kategorie

P/B-Verhältnis für Joyzyme Group Limited (8622)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Joyzyme Group Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Joyzyme Group Limited von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber